Pali Rastogi, Arpita Thakur, Ram ghulam Razdan




Objective of the study

The objective of the study was to assess and compare serum calcium and magnesium level in Depression patients and healthy controls and to find out correlation of serum Mg++ and Ca++ levels with Depression. Depression is reported to be the most common mood disorder which can be manifest as a single episode or as recurrent episodes. Globally, the proportion of the population affected with depression is estimated to be 4.4%. In one of the reports of the World Health Organization, depression and heart disease will be the most common diseases on Earth by 2020. Methodology: The study is based on a sample of 200 subjects – 100 healthy normal individuals and 100 patients, from Department of Psychiatry, Mahatma Gandhi Memorial Medical College and M. Y. Hospital, Indore, who were diagnosed as having Depression as per the ICD-10 criteria. Estimation of the parameters of the study was done by using spectrophotometer (Spectra scan UV 2600). The result values of both the groups were compared by using SPSS 23 for windows were used for data analysis. Results: Analysis of data reveals the mean value of serum magnesium among subjects of the case group was lowered then compared to the subjects of the control group. The differences in mean values were found to be statistically significant. While in case of serum calcium, Case group has shown less serum calcium levels than control group, but it was not statistically significant. Conclusion: The present study shows that alterations in the concentrations of magnesium and calcium may play a role in depressive illnesses and thus, may have a possible role in causing various mood disorders like MDD.




Full Text:



Depression and other common mental disorders: global health estimates. Geneva: World Health Organization; 2017

WHO. Health statistics and information systems – Estimates for 2000– 2015 Geneva: World Health Organization; 2017 (http://www.who.int/healthinfo/global_burden_disease/estimates/en/, accessed 25 March 2017).

GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with

disability for 310 diseases and injuries, 1990-2015: a systematic analysis

for the Global Burden of Disease Study 2015. Lancet. 2016;388:1545–602.

Üstün TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJL. Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004;184:386–92.

Joffe RT, Levitt AJ, Young LT. The thyroid, magnesium and calcium in major depression. Biol Psychiatry. 1996;40:428-9

Mayer ML, Westbrook GL. Permeation and block of N-methylD-aspartic acid receptor channels by divalent cations in mouse cultured central neurons. J Physiol . 1987

Bear MF, Connors BW, Paradiso MA. Neurotransmitter systems. In: Neuroscience exploring the brain. Baltimore, MD: Lippincott Williams and Wilkins; 2001. p. 131–62.

Mark LP, Prost RW, Ulmer JL, et al. Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging. AJNR Am J Neuroradiol 2001;22:1813–24.

Kandel ER, Schwartz JH, Jessell TM. Synaptic integration. In: Essentials of neural science and behavior. Stamford, CT: Appleton and Lange; 1995. p. 219–41.

McMenimen KA, Dougherty DA, Lester HA, Petersson EJ. Probing the Mg 2+ blockade site of an N-methyl-D-aspartate (NMDA) receptor with unnatural amino acid mutagenesis. ACS Chem Biol 2006;1:227–34

Sattler R, Tymianski M. Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol Neurobiol. 2001;24:107-29.

Bear MF, Connors BW, Paradiso MA. Neurotransmitter systems. In: Neuroscience exploring the brain. Baltimore, MD: Lippincott Williams and Wilkins; 2001. p. 131–62.

Gillessen T, Budd SL, Lipton SA. Excitatory amino acid neurotoxicity. In: Alzheimer C, editor. Molecular and cellular biology of neuro-protection in the CNS series: advances in experimental medicine and biology, vol. 513. NewYork, NY: Kluwer Academic/Plenum Publishers, Georgetown, TX: Landes Bioscience; 2002. p. 3–40

Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 1991;14:60-7

Blaylock RL. Food additive excitotoxins and degenerative brain disorders. Med Sentinel 1999;4:212–5

Carafoli E. Calcium – a universal carrier of biological signals. FEBS J 2005;272:1073–89.

Boulton CL, Irving AJ, Southam E, Potier B, Garthwaite J, Collingridge GL. The nitric oxide--cyclic GMP pathway and synaptic depression in rat hippocampal slices. Eur J Neurosci. 1994;6:1528-35

Wang X, Robinson PJ. Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system. J Neurochem. 1997;68:443-56.

Lev-Ram V, Jiang T, Wood J, Lawrence DS, Tsien RY. Synergies and coincidence requirements between NO, cGMP, and Ca2+ in the induction of cerebellar long-term depression. Neuron. 1997;18:1025-38.

Park SC, Hahn SW, Hwang TY, et al. Does age at onset of first major depressive episode indicate the subtype of major depressive disorder?: the clinical research center for depression study. Yonsei Med J. 2014;55(6):1712–1720. Doi : 10.3349/ymj. 2014.55.6.1712

Yang F, Li Y, Xie D, Shao C, Ren J, Wu W, et al. Age at onset of major depressive disorder in Han Chinese women: relationship with clinical features and family history. J Affect Disord. 2011;135:89–94.

Srivastava A S, Kumar R. Suicidal ideation and attempts in patients with major depression: Sociodemographic and clinical variables. Indian J Psychiatry 2005;47:225-8

Wade TJ, Cairney J: Age and depression in a nationally representative sample of Canadians: a preliminary look at the National Population Health Survey. Can J PublicHealth. 1997, 88: 297-302.

Wade TJ, Cairney J: The effect of sociodemographics, social stressors, health status and psychosocial resources on the age-depression relationship. Can J Public Health. 2000, 91: 307-312.

Streiner DL, Cairney J, Veldhuizen S: The epidemiology of psychological problems in the elderly. Can J Psychiatry. 2006, 51: 185-191.

Patten SB, Wang JL, Williams JV, et al. Descriptive epidemiology of major depression in Canada. Can J Psychiatry. 2006;51:84–90.

Deb N, Lahon D, Chakravarty S. A study of serum magnesium and serum

calcium in major depressive disorder. Open J Psychiatry Allied Sci.

;7:70-4. doi: 10.5958/2394-2061.2016.00012.4. Epub 2015 Dec 16.

Banki CM, Vojnik M, Papp Z, Balla KZ, Arato M: Cerebrospinal fluid magnesium and calcium related to amine metabolites, diagnosis, and suicide attempts. Biol Psychiatry, 1985, 20, 163–171.

Linder, J., Brismar, K., Beck-Friis, J., Saaf, J., & Wetterberg, L. (1989). Calcium and magnesium concentrations in affective disorder: difference between plasma and serum in relation to symptoms. Acta Psychiatrica Scandinavica, 80(6), 527–537

Levine, J., Stein, D., Rapoport, A., & Kurtzman, L. (1999). High Serum and Cerebrospinal Fluid Ca/Mg Ratio in Recently Hospitalized Acutely Depressed Patients. Neuropsychobiology, 39(2), 63–70

Hashizume N, Mori M: An analysis of hypermagnesemia and hypomagnesemia. Jpn J Med, 1990, 29, 368–372.

Ziêba A, Kata R, Dudek D, Schlegel-Zawadzka M, Nowak G: Serum trace elements in animal models and human depression: Part III. Magnesium. Relationship with Copper. Hum Psychopharmacol Clin Exp, 2000, 15,631–63

Arragan-Rodríguez L, Rodríguez-Morán M, Guerrero-Romero F. Depressive symptoms and hypomagnesemia in older diabetic subjects. Arch Med Res 2007;38:752–6


  • There are currently no refbacks.